Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients. by Sandra Heskamp, Otto C Boerman, Janneke D M Molkenboer-Kuenen, Carla A Wauters, Luc J A Strobbe, Caroline M P W Mandigers, Peter Bult, Wim J G Oyen, Winette T A van der Graaf, Hanneke W M van Laarhoven

Get full text